{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:22:52Z","timestamp":1788348172061,"version":"build-2803163510"},"reference-count":293,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP2 DK128799-01"],"award-info":[{"award-number":["DP2 DK128799-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK135478"],"award-info":[{"award-number":["R01DK135478"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21bm0404045h0003"],"award-info":[{"award-number":["JP21bm0404045h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18bm0704025h0001"],"award-info":[{"award-number":["JP18bm0704025h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21fk0210060h0003"],"award-info":[{"award-number":["JP21fk0210060h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21gm1210012h0002"],"award-info":[{"award-number":["JP21gm1210012h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fk0210037h0001"],"award-info":[{"award-number":["JP18fk0210037h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["UG3\/UH3 DK119982"],"award-info":[{"award-number":["UG3\/UH3 DK119982"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004398","name":"Mitsubishi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010327","name":"Cincinnati Children\u2019s Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003382","name":"Core Research for Evolutional Science and Technology","doi-asserted-by":"publisher","award":["20gm1210012h0001"],"award-info":[{"award-number":["20gm1210012h0001"]}],"id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJMS2033-12"],"award-info":[{"award-number":["JPMJMS2033-12"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJMS2022-10"],"award-info":[{"award-number":["JPMJMS2022-10"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18H02800"],"award-info":[{"award-number":["JP18H02800"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K22416"],"award-info":[{"award-number":["19K22416"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.dmpk.2025.101478","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T21:11:53Z","timestamp":1741900313000},"page":"101478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["In vitro liver models for toxicological research"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6897-0076","authenticated-orcid":false,"given":"Ichiro","family":"Fukunaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Takebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/hep.28886","article-title":"Stem cell\u2013derived models to improve mechanistic understanding and prediction of human drug\u2010induced liver injury","volume":"65","author":"Goldring","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dmpk.2025.101478_bib2","first-page":"233","article-title":"Drug-induced hepatotoxicity: a review","author":"Pandit","year":"2012","journal-title":"J Appl Pharmaceut Sci"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-bioeng-060418-052305","article-title":"Challenges and opportunities in the design of liver-on-chip microdevices","volume":"21","author":"Ehrlich","year":"2019","journal-title":"Annu Rev Biomed Eng"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib4","article-title":"Recent advances in liver\u2010on\u2010chips: design, fabrication, and applications","volume":"2","author":"Qiu","year":"2023","journal-title":"Smart Medicine"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.dmpk.2025.101478_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00002018-200124070-00001","article-title":"Drug-induced liver disorders: implications for drug development and regulation","volume":"24","author":"Kaplowitz","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.dmpk.2025.101478_bib7","unstructured":"Zakim D, Boyer TD. Hepatology: a textbook of liver disease. (No Title)."},{"key":"10.1016\/j.dmpk.2025.101478_bib8","series-title":"Organizational principles. The liver: biology and pathobiology","author":"Desmet","year":"2001"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-physiol-021113-170255","article-title":"Cellular homeostasis and repair in the mammalian liver","volume":"77","author":"Stanger","year":"2015","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.dmpk.2025.101478_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0159-5","article-title":"The global burden of liver disease: a challenge for methods and for public health","volume":"12","author":"Byass","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.dmpk.2025.101478_bib12","series-title":"Food, drug, and cosmetic act","author":"Lam","year":"2022"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1142\/S2339547815300012","article-title":"Microengineered cell and tissue systems for drug screening and toxicology applications: evolution of in-vitro liver technologies","volume":"3","author":"Usta","year":"2015","journal-title":"Technology"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/2211068214566939","article-title":"Microengineered liver tissues for drug testing","volume":"20","author":"Khetani","year":"2015","journal-title":"J Lab Autom"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","author":"Martignoni","year":"2006","journal-title":"Expet Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.dmpk.2025.101478_bib16","series-title":"The principles of humane experimental technique","author":"Russell","year":"1959"},{"key":"10.1016\/j.dmpk.2025.101478_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/d41586-024-02314-8","article-title":"Animal research is not always king: researchers should explore the alternatives","volume":"631","author":"Editorial","year":"2024","journal-title":"Nature"},{"issue":"6628","key":"10.1016\/j.dmpk.2025.101478_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1126\/science.adg6276","article-title":"FDA no longer needs to require animal tests before human drug trials","volume":"379","author":"Wadman","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.dmpk.2025.101478_bib19","series-title":"FDA Modernization Act 2.0 allows for alternatives to animal testing","author":"Han","year":"2023"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cbi.2004.09.011","article-title":"Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential","volume":"150","author":"Xu","year":"2004","journal-title":"Chem Biol Interact"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib20","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1021\/acs.chemrestox.6b00150","article-title":"Novel 3D culture systems for studies of human liver function and assessments of the hepatotoxicity of drugs and drug candidates","volume":"29","author":"Lauschke","year":"2016","journal-title":"Chem Res Toxicol"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101478_bib21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.stem.2021.04.005","article-title":"Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids","volume":"28","author":"Marsee","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.dmpk.2025.101478_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxlet.2018.10.030","article-title":"Proteomic responses of HepG2 cell monolayers and 3D spheroids to selected hepatotoxins","volume":"300","author":"Hurrell","year":"2019","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.dmpk.2025.101478_bib28","first-page":"1083","article-title":"A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies","volume":"88","author":"Ramaiahgari","year":"2014","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.dmpk.2025.101478_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tiv.2018.02.013","article-title":"Characterization and reproducibility of HepG2 hanging drop spheroids toxicology in vitro","volume":"50","author":"Hurrell","year":"2018","journal-title":"Toxicol Vitro"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101478_bib31","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/1087057106292763","article-title":"Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis","volume":"11","author":"Ivascu","year":"2006","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.dmpk.2025.101478_bib32","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1007\/s00204-019-02552-0","article-title":"High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability","volume":"93","author":"Hiemstra","year":"2019","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/toxsci\/kft021","article-title":"3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies","volume":"133","author":"Gunness","year":"2013","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib42","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150034","article-title":"3D spheroid cultures improve the metabolic gene expression profiles of HepaRG cells","volume":"35","author":"Takahashi","year":"2015","journal-title":"Biosci Rep"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/toxsci\/kfs232","article-title":"Three-dimensional HepaRG model as an attractive tool for toxicity testing","volume":"130","author":"Leite","year":"2012","journal-title":"Toxicol Sci"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib56","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/toxsci\/kfx289","article-title":"Comparison of hepatic 2D sandwich cultures and 3D spheroids for long-term toxicity applications: a multicenter study","volume":"162","author":"Bell","year":"2018","journal-title":"Toxicol Sci"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib57","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/dmd.116.074369","article-title":"Transcriptional, functional, and mechanistic comparisons of stem cell\u2013derived hepatocytes, HepaRG cells, and three-dimensional human hepatocyte spheroids as predictive in vitro systems for drug-induced liver injury","volume":"45","author":"Bell","year":"2017","journal-title":"Drug Metabol Dispos"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib58","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/toxsci\/kfy058","article-title":"Prediction of drug-induced hepatotoxicity using long-term stable primary hepatic 3D spheroid cultures in chemically defined conditions","volume":"163","author":"Vorrink","year":"2018","journal-title":"Toxicol Sci"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib62","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2018.11.013","article-title":"Long-term expansion of functional mouse and human hepatocytes as 3D organoids","volume":"175","author":"Hu","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib66","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101478_bib67","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/nprot.2016.097","article-title":"Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation","volume":"11","author":"Broutier","year":"2016","journal-title":"Nat Protoc"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101478_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110778","article-title":"Development of a hepatic differentiation method in 2D culture from primary human hepatocyte-derived organoids for pharmaceutical research","volume":"27","author":"Ueyama-Toba","year":"2024","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79082-8","article-title":"Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease","volume":"10","author":"Verstegen","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib74","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.stem.2018.10.018","article-title":"In vitro expansion of primary human hepatocytes with efficient liver repopulation capacity","volume":"23","author":"Zhang","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib75","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jhep.2018.09.007","article-title":"Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells","volume":"70","author":"Kim","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib76","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13287-024-03877-z","article-title":"Generation of human hepatobiliary organoids with a functional bile duct from chemically induced liver progenitor cells","volume":"15","author":"Li","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"15","key":"10.1016\/j.dmpk.2025.101478_bib95","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.3390\/cells12151982","article-title":"Guiding hepatic differentiation of pluripotent stem cells using 3D microfluidic Co-cultures with human hepatocytes","volume":"12","author":"Fattahi","year":"2023","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.dmpk.2025.101478_bib104","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.celrep.2017.11.005","article-title":"Massive and reproducible production of liver buds entirely from human pluripotent stem cells","volume":"21","author":"Takebe","year":"2017","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib106","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jhep.2018.12.028","article-title":"Generation of hepatobiliary organoids from human induced pluripotent stem cells","volume":"70","author":"Wu","year":"2019","journal-title":"J Hepatol"},{"issue":"17","key":"10.1016\/j.dmpk.2025.101478_bib107","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94954","article-title":"Human hepatic organoids for the analysis of human genetic diseases","volume":"2","author":"Guan","year":"2017","journal-title":"JCI insight"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib108","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","article-title":"Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids","volume":"30","author":"Ouchi","year":"2019","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib109","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","article-title":"High-fidelity drug-induced liver injury screen using human pluripotent stem cell\u2013derived organoids","volume":"160","author":"Shinozawa","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib268","doi-asserted-by":"crossref","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib269","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/toxsci\/kfz195","article-title":"Mechanisms of chronic fialuridine hepatotoxicity as revealed in primary human hepatocyte spheroids","volume":"171","author":"Hendriks","year":"2019","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.dmpk.2025.101478_bib270","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122360","article-title":"Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: application in regenerative medicine, disease modeling, and toxicology testing","volume":"303","author":"Salas-Silva","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.dmpk.2025.101478_bib271","article-title":"Three-dimensional human bile duct formation from chemically induced human liver progenitor cells","volume":"11","author":"Li","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101478_bib272","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jhep.2023.01.019","article-title":"A human liver organoid screening platform for DILI risk prediction","volume":"78","author":"Zhang","year":"2023","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib273","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.stemcr.2018.01.006","article-title":"Human iPSC-derived posterior gut progenitors are expandable and capable of forming gut and liver organoids","volume":"10","author":"Zhang","year":"2018","journal-title":"Stem Cell Rep"},{"issue":"5739","key":"10.1016\/j.dmpk.2025.101478_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/282615a0","article-title":"Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line","volume":"282","author":"Aden","year":"1979","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib23","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1021\/acs.chemrestox.1c00227","article-title":"Evaluation of a three-dimensional primary human hepatocyte spheroid model: adoption and industrialization for the enhanced detection of drug-induced liver injury","volume":"34","author":"Schofield","year":"2021","journal-title":"Chem Res Toxicol"},{"issue":"15","key":"10.1016\/j.dmpk.2025.101478_bib24","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1177\/1535370216657448","article-title":"Cell sources for in vitro human liver cell culture models","volume":"241","author":"Zeilinger","year":"2016","journal-title":"Exp Biol Med"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101478_bib25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1248\/bpb.b17-00913","article-title":"Comparison of drug metabolism and its related hepatotoxic effects in HepaRG, cryopreserved human hepatocytes, and HepG2 cell cultures","volume":"41","author":"Yokoyama","year":"2018","journal-title":"Biol Pharmaceut Bull"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101478_bib30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/1087057116651867","article-title":"Reproducibility of uniform spheroid formation in 384-well plates: the effect of medium evaporation","volume":"21","author":"Das","year":"2016","journal-title":"J Biomol Screen"},{"issue":"24","key":"10.1016\/j.dmpk.2025.101478_bib33","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","article-title":"The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics","volume":"168","author":"Guillouzo","year":"2007","journal-title":"Chem Biol Interact"},{"issue":"7","key":"10.1016\/j.dmpk.2025.101478_bib35","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1517\/17425255.2012.685159","article-title":"The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human","volume":"8","author":"Andersson","year":"2012","journal-title":"Expet Opin Drug Metabol Toxicol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/dmd.105.006759","article-title":"Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells","volume":"34","author":"Aninat","year":"2006","journal-title":"Drug Metabol Dispos: Biol Fate Chem"},{"key":"10.1016\/j.dmpk.2025.101478_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","article-title":"Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins","volume":"28","author":"Gerets","year":"2012","journal-title":"Cell Biol Toxicol"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.taap.2008.11.008","article-title":"Dose-and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells","volume":"234","author":"Lambert","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101478_bib39","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1039\/D1BM01872H","article-title":"In vitro functional models for human liver diseases and drug screening: beyond animal testing","volume":"11","author":"Paradiso","year":"2023","journal-title":"Biomater Sci"},{"key":"10.1016\/j.dmpk.2025.101478_bib40","series-title":"A comprehensive guide to toxicology in nonclinical drug development","first-page":"843","article-title":"Application of evolving computational and biological platforms for chemical safety assessment","author":"Settivari","year":"2017"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1124\/jpet.112.195834","article-title":"In vitro evaluation of major in vivo drug metabolic pathways using primary human hepatocytes and HepaRG cells in suspension and a dynamic three-dimensional bioreactor system","volume":"343","author":"Darnell","year":"2012","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/toxsci\/kfx122","article-title":"From the cover: three-dimensional (3D) HepaRG spheroid model with physiologically relevant xenobiotic metabolism competence and hepatocyte functionality for liver toxicity screening","volume":"159","author":"Ramaiahgari","year":"2017","journal-title":"Toxicol Sci"},{"issue":"1\u20132","key":"10.1016\/j.dmpk.2025.101478_bib46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0169-409X(96)00418-8","article-title":"Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatocytes","volume":"22","author":"LeCluyse","year":"1996","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib47","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/0006-2952(82)90521-4","article-title":"Long-term maintenance and induction of cytochrome P-450 in primary cultures of rat hepatocytes","volume":"31","author":"Nelson","year":"1982","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib48","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2174\/138920005774832632","article-title":"A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction","volume":"6","author":"Sivaraman","year":"2005","journal-title":"Curr Drug Metabol"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0928-0987(01)00135-X","article-title":"Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation","volume":"13","author":"LeCluyse","year":"2001","journal-title":"Eur J Pharmaceut Sci"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/toxsci\/53.1.56","article-title":"Characterization of nitric oxide production following isolation of rat hepatocytes","volume":"53","author":"Tirmenstein","year":"2000","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.dmpk.2025.101478_bib51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF02628491","article-title":"A quantitative analysis of lectin binding to adult rat hepatocyte cell surfaces","volume":"24","author":"Jauregui","year":"1988","journal-title":"In Vitro Cell Dev Biol"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101478_bib52","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/hep.28780","article-title":"Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiation","volume":"64","author":"Lauschke","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.dmpk.2025.101478_bib53","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3389\/fphar.2019.01093","article-title":"Comprehensive evaluation of organotypic and microphysiological liver models for prediction of drug-induced liver injury","volume":"10","author":"Zhou","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.dmpk.2025.101478_bib54","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00204-016-1694-y","article-title":"Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile","volume":"91","author":"Heslop","year":"2017","journal-title":"Arch Toxicol"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib55","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1083\/jcb.116.4.1043","article-title":"Hepatocytes in collagen sandwich: evidence for transcriptional and translational regulation","volume":"116","author":"Dunn","year":"1992","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1039\/C2TX20051A","article-title":"In vitro models for liver toxicity testing","volume":"2","author":"Soldatow","year":"2013","journal-title":"Toxicol Res"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib60","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/00498250210128675","article-title":"Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells","volume":"32","author":"Rodr\u00edguez-Antona","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmpk.2025.101478_bib61","first-page":"1","article-title":"General review on in vitro hepatocyte models and their applications","author":"Guguen-Guillouzo","year":"2010","journal-title":"Hepatocytes: Method Protocol"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib63","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1038\/emboj.2012.149","article-title":"Adult mammalian stem cells: the role of Wnt, Lgr5 and R\u2010spondins","volume":"31","author":"Schuijers","year":"2012","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib64","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2009.080758","article-title":"Wnt signaling, lgr5, and stem cells in the intestine and skin","volume":"174","author":"Haegebarth","year":"2009","journal-title":"Am J Pathol"},{"issue":"7436","key":"10.1016\/j.dmpk.2025.101478_bib65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature11826","article-title":"In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration","volume":"494","author":"Huch","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib70","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hep.31252","article-title":"Regional differences in human biliary tissues and corresponding in vitro\u2013derived organoids","volume":"73","author":"Rimland","year":"2021","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.dmpk.2025.101478_bib71","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.4161\/cc.3.11.1212","article-title":"Gene expression profile at the G1\/S transition of liver regeneration after partial hepatectomy in mice","volume":"3","author":"Satyanarayana","year":"2004","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.stem.2019.11.001","article-title":"Broad distribution of hepatocyte proliferation in liver homeostasis and regeneration","volume":"26","author":"Chen","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib73","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.cell.2018.11.012","article-title":"Inflammatory cytokine TNF\u03b1 promotes the long-term expansion of primary hepatocytes in 3D culture","volume":"175","author":"Peng","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib77","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/jhep.2001.23314","article-title":"Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus","volume":"33","author":"Dandri","year":"2001","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101478_bib78","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.dmpk.2025.101478_bib79","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0040-1701444","article-title":"Art of making artificial liver: depicting human liver biology and diseases in mice","volume":"40","author":"Sugahara","year":"2020","journal-title":"Semin Liver Dis"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101478_bib80","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/00498250500307251","article-title":"Evaluation of mRNA expression of human drug-metabolizing enzymes and transporters in chimeric mouse with humanized liver","volume":"35","author":"Nishimura","year":"2005","journal-title":"Xenobiotica"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib81","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1124\/dmd.114.057646","article-title":"Validation of uPA\/SCID mouse with humanized liver as a human liver model: protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases by LC-MS\/MS","volume":"42","author":"Ohtsuki","year":"2014","journal-title":"Drug Metabol Dispos: Biol Fate Chem"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib82","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.104.001347","article-title":"Expression of human cytochromes P450 in chimeric mice with humanized liver","volume":"32","author":"Katoh","year":"2004","journal-title":"Drug Metabol Dispos"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101478_bib83","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.105.005157","article-title":"Expression of human phase II enzymes in chimeric mice with humanized liver","volume":"33","author":"Katoh","year":"2005","journal-title":"Drug Metabol Dispos"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib84","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jcp.30610","article-title":"Liver\u2010humanized mice: a translational strategy to study metabolic disorders","volume":"237","author":"Luo","year":"2022","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib85","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.dmpk.2014.10.009","article-title":"Significance of aldehyde oxidase during drug development: effects on drug metabolism, pharmacokinetics, toxicity, and efficacy","volume":"30","author":"Sanoh","year":"2015","journal-title":"Drug Metabol Pharmacokinet"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib86","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00498254.2013.867553","article-title":"Chimeric rodents with humanized liver: bridging the preclinical\/clinical trial gap in ADME\/toxicity studies","volume":"44","author":"Foster","year":"2014","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib87","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jps.20783","article-title":"In vivo drug metabolism model for human cytochrome P450 enzyme using chimeric mice with humanized liver","volume":"96","author":"Katoh","year":"2007","journal-title":"J Pharmaceut Sci"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib88","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.dmpk.2017.11.001","article-title":"Chimeric mice with humanized liver: application in drug metabolism and pharmacokinetics studies for drug discovery","volume":"33","author":"Naritomi","year":"2018","journal-title":"Drug Metabol Pharmacokinet"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib89","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1038\/s41598-017-07434-y","article-title":"Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice","volume":"7","author":"Van De Garde","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.dmpk.2025.101478_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008453","article-title":"Genetic mapping of fitness determinants across the malaria parasite Plasmodium falciparum life cycle","volume":"15","author":"Li","year":"2019","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib91","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.29891","article-title":"Acute hepatitis B virus infection in humanized chimeric mice has multiphasic viral kinetics","volume":"68","author":"Ishida","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib92","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.24758","article-title":"Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation","volume":"55","author":"L\u00fctgehetmann","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib93","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/v8060176","article-title":"Mouse systems to model hepatitis C virus treatment and associated resistance","volume":"8","author":"Mesalam","year":"2016","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101478_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237809","article-title":"Culture density contributes to hepatic functions of fresh human hepatocytes isolated from chimeric mice with humanized livers: novel, long-term, functional two-dimensional in vitro tool for developing new drugs","volume":"15","author":"Yamasaki","year":"2020","journal-title":"PLoS One"},{"issue":"5391","key":"10.1016\/j.dmpk.2025.101478_bib96","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101478_bib97","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"5858","key":"10.1016\/j.dmpk.2025.101478_bib98","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.dmpk.2025.101478_bib99","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.2174\/138920111798377120","article-title":"Stem cells in pharmaceutical biotechnology","volume":"12","author":"K Zuba-Surma","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.23354","article-title":"Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells","volume":"51","author":"Si-Tayeb","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib101","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2015.05.013","article-title":"Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells","volume":"63","author":"Godoy","year":"2015","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib102","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2014.10.016","article-title":"Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes","volume":"62","author":"Baxter","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib103","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nprot.2012.153","article-title":"Production of hepatocyte-like cells from human pluripotent stem cells","volume":"8","author":"Hannan","year":"2013","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2018.05.027","article-title":"Generation of hepatic stellate cells from human pluripotent stem cells enables in vitro modeling of liver fibrosis","volume":"23","author":"Coll","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.dmpk.2025.101478_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.574047","article-title":"Liver organoids: recent developments, limitations and potential","volume":"8","author":"Harrison","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.dmpk.2025.101478_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.626805","article-title":"A critical perspective on 3D liver models for drug metabolism and toxicology studies","volume":"9","author":"Serras","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib112","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10565-017-9383-z","article-title":"A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines","volume":"33","author":"Gao","year":"2017","journal-title":"Cell Biol Toxicol"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib113","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jbt.20179","article-title":"Ontogeny of human hepatic cytochromes P450","volume":"21","author":"Hines","year":"2007","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.dmpk.2025.101478_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-020-00537-x","article-title":"Human fetal liver metabolism of oxycodone is mediated by CYP3A7","volume":"23","author":"Shum","year":"2021","journal-title":"AAPS J"},{"key":"10.1016\/j.dmpk.2025.101478_bib115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s43188-024-00275-8","article-title":"Current hPSC-derived liver organoids for toxicity testing: cytochrome P450 enzymes and drug metabolism","volume":"41","author":"Kim","year":"2025","journal-title":"Toxicol Res"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101478_bib116","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1124\/dmd.30.8.883","article-title":"Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7","volume":"30","author":"Williams","year":"2002","journal-title":"Drug Metabol Dispos"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib117","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/bbrc.2000.4066","article-title":"Functionally conserved xenobiotic responsive enhancer in cytochrome P450 3A7","volume":"280","author":"Bertilsson","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib118","first-page":"37","article-title":"Drug metabolism in the human fetus and newborn infant","volume":"19","author":"Rane","year":"1972","journal-title":"Pediatr Clin"},{"issue":"20","key":"10.1016\/j.dmpk.2025.101478_bib119","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0024-3205(70)90038-X","article-title":"The presence of a monooxygenase system in human fetal liver microsomes","volume":"9","author":"Yaffe","year":"1970","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib120","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0163-7258(99)00046-7","article-title":"Fetal hepatic drug elimination","volume":"84","author":"Ring","year":"1999","journal-title":"Pharmacol Therapeut"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib121","article-title":"Liver three-dimensional cellular models for high-throughput chemical testing","volume":"3","author":"Yang","year":"2023","journal-title":"Cell Rep Methods"},{"key":"10.1016\/j.dmpk.2025.101478_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2021.107083","article-title":"Characterization of a commercially available line of iPSC hepatocytes as models of hepatocyte function and toxicity for regulatory purposes","volume":"110","author":"Qosa","year":"2021","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib123","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4174\/jkss.2013.84.4.202","article-title":"Successful mouse hepatocyte culture with sandwich collagen gel formation","volume":"84","author":"Choi","year":"2013","journal-title":"J Korean Surg Soc"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib124","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1517\/17425251003674356","article-title":"Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity","volume":"6","author":"Meng","year":"2010","journal-title":"Expet Opin Drug Metabol Toxicol"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101478_bib125","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1007\/s00204-024-03757-8","article-title":"Formation of functional, extended bile canaliculi, and increased bile acid production in sandwich-cultured human cryopreserved hepatocytes using commercially available culture medium","volume":"98","author":"Horiuchi","year":"2024","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19469-x","article-title":"Construction of a culture protocol for functional bile canaliculi formation to apply human iPS cell-derived hepatocytes for cholestasis evaluation","volume":"12","author":"Horiuchi","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib127","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/hep.27621","article-title":"Enhancing the functional maturity of induced pluripotent stem cell\u2013derived human hepatocytes by controlled presentation of cell\u2013cell interactions in vitro","volume":"61","author":"Berger","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dmpk.2025.101478_bib128","series-title":"Cooperation of liver cells in health and disease: with 18 tables","author":"Kmiec","year":"2001"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib129","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.22034","article-title":"Liver: an organ with predominant innate immunity","volume":"47","author":"Gao","year":"2008","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.dmpk.2025.101478_bib130","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.3390\/ijms24076248","article-title":"Three-dimensional cell Co-culture liver models and their applications in pharmaceutical research","volume":"24","author":"Ma","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"20","key":"10.1016\/j.dmpk.2025.101478_bib274","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1007\/s00018-015-1970-7","article-title":"Regulation of hepatocyte identity and quiescence","volume":"72","author":"Berasain","year":"2015","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib275","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5082\/5\/4\/045008","article-title":"Layered long-term co-culture of hepatocytes and endothelial cells on a transwell membrane: toward engineering the liver sinusoid","volume":"5","author":"Kang","year":"2013","journal-title":"Biofabrication"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101478_bib276","first-page":"534","article-title":"Three-dimensional spheroid primary human hepatocytes in monoculture and coculture with nonparenchymal cells. Tissue engineering Part C","volume":"24","author":"Baze","year":"2018","journal-title":"Methods"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib277","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcmgh.2017.11.007","article-title":"A cell culture platform to maintain long-term phenotype of\u00a0Primary human hepatocytes and endothelial cells","volume":"5","author":"Ware","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib278","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver sinusoidal endothelial cells: physiology and role in liver diseases","volume":"66","author":"Poisson","year":"2017","journal-title":"J Hepatol"},{"issue":"43","key":"10.1016\/j.dmpk.2025.101478_bib279","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.3748\/wjg.v23.i43.7666","article-title":"Pathological process of liver sinusoidal endothelial cells in liver diseases","volume":"23","author":"Ni","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101478_bib280","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib281","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib282","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/hep.23640","article-title":"Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice","volume":"52","author":"Lang","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib283","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ajpath.2012.10.014","article-title":"Lipopolysaccharide causes an increase in intestinal tight junction permeability <em>in\u00a0Vitro<\/em> and <em>in\u00a0Vivo<\/em> by inducing enterocyte membrane expression and localization of TLR-4 and CD14","volume":"182","author":"Guo","year":"2013","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib284","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/labinvest.2010.123","article-title":"Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats","volume":"90","author":"Liu","year":"2010","journal-title":"Lab Invest"},{"issue":"13","key":"10.1016\/j.dmpk.2025.101478_bib285","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1158\/1078-0432.CCR-09-2904","article-title":"Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects","volume":"16","author":"Zhang","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib153","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5082\/5\/4\/045008","article-title":"Layered long-term co-culture of hepatocytes and endothelial cells on a transwell membrane: toward engineering the liver sinusoid","volume":"5","author":"Kang","year":"2013","journal-title":"Biofabrication"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib131","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/toxsci\/kfx059","article-title":"Exploring chronic drug effects on microengineered human liver cultures using global gene expression profiling","volume":"157","author":"Ware","year":"2017","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib132","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/toxsci\/kfs326","article-title":"Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans","volume":"132","author":"Khetani","year":"2013","journal-title":"Toxicol Sci"},{"issue":"11","key":"10.1016\/j.dmpk.2025.101478_bib133","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1163\/156856298X00695","article-title":"Probing heterotypic cell interactions: hepatocyte function in microfabricated co-cultures","volume":"9","author":"Bhatia","year":"1998","journal-title":"J Biomater Sci"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib134","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1021\/bp980036j","article-title":"Microfabrication of hepatocyte\/fibroblast co\u2010cultures: role of homotypic cell interactions","volume":"14","author":"Bhatia","year":"1998","journal-title":"Biotechnol Prog"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib135","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jcmgh.2017.11.012","article-title":"Bioengineered liver models for drug testing and cell differentiation studies","volume":"5","author":"Underhill","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib136","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1124\/dmd.115.066688","article-title":"Application of a micropatterned cocultured hepatocyte system to predict preclinical and human-specific drug metabolism","volume":"44","author":"Ballard","year":"2016","journal-title":"Drug Metabol Dispos"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib137","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1124\/dmd.113.053397","article-title":"Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac","volume":"41","author":"Chan","year":"2013","journal-title":"Drug Metabol Dispos"},{"issue":"7","key":"10.1016\/j.dmpk.2025.101478_bib138","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/ten.tec.2014.0512","article-title":"Hormone and drug-mediated modulation of glucose metabolism in a microscale model of the human liver","volume":"21","author":"Davidson","year":"2015","journal-title":"Tissue Eng C Methods"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib139","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/dmd.115.067173","article-title":"Application of micropatterned cocultured hepatocytes to evaluate the inductive potential and degradation rate of major xenobiotic metabolizing enzymes","volume":"44","author":"Dixit","year":"2016","journal-title":"Drug Metabol Dispos"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nbt1361","article-title":"Microscale culture of human liver cells for drug development","volume":"26","author":"Khetani","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib141","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1208\/s12248-016-0019-7","article-title":"Metabolic profiling of human long-term liver models and hepatic clearance predictions from in vitro data using nonlinear mixed-effects modeling","volume":"19","author":"Kratochwil","year":"2017","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib142","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1124\/dmd.115.066027","article-title":"Prediction of drug clearance and drug-drug interactions in microscale cultures of human hepatocytes","volume":"44","author":"Lin","year":"2016","journal-title":"Drug Metabol Dispos"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib143","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.chom.2013.06.005","article-title":"A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax","volume":"14","author":"March","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib144","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1124\/dmd.116.072660","article-title":"Evaluation of the interplay between uptake transport and CYP3A4 induction in micropatterned cocultured hepatocytes","volume":"44","author":"Moore","year":"2016","journal-title":"Drug Metabol Dispos"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib145","first-page":"215","article-title":"Hypoxia promotes liver-stage malaria infection in primary human hepatocytes in vitro","volume":"7","author":"Ng","year":"2014","journal-title":"Dis Model; Mech"},{"issue":"7","key":"10.1016\/j.dmpk.2025.101478_bib146","first-page":"3141","article-title":"Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures","volume":"107","author":"Ploss","year":"2010","journal-title":"Proceedings of the"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib147","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1124\/dmd.113.055897","article-title":"Bridging in vitro and in vivo metabolism and transport of faldaprevir in human using a novel cocultured human hepatocyte system, HepatoPac","volume":"42","author":"Ramsden","year":"2014","journal-title":"Drug Metabol Dispos"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib148","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/dmd.113.055947","article-title":"Generating an in vitro\u2013in vivo correlation for metabolism and liver enrichment of a hepatitis C virus drug, faldaprevir, using a Rat Hepatocyte Model (HepatoPac)","volume":"42","author":"Ramsden","year":"2014","journal-title":"Drug Metabol Dispos"},{"issue":"33","key":"10.1016\/j.dmpk.2025.101478_bib149","doi-asserted-by":"crossref","first-page":"12193","DOI":"10.1073\/pnas.1412631111","article-title":"Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems","volume":"111","author":"Shlomai","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1089\/adt.2013.525","article-title":"A micropatterned hepatocyte coculture model for assessment of liver toxicity using high-content imaging analysis","volume":"12","author":"Trask","year":"2014","journal-title":"Assay Drug Dev Technol"},{"issue":"10","key":"10.1016\/j.dmpk.2025.101478_bib151","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1124\/dmd.110.034876","article-title":"Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites","volume":"38","author":"Wang","year":"2010","journal-title":"Drug Metabol Dispos"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib152","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/toxsci\/kfv048","article-title":"Prediction of drug-induced liver injury in micropatterned Co-cultures containing iPSC-derived human hepatocytes","volume":"145","author":"Ware","year":"2015","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.dmpk.2025.101478_bib154","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.fct.2019.04.057","article-title":"Development of a two-layer transwell co-culture model for the in vitro investigation of pyrrolizidine alkaloid-induced hepatic sinusoidal damage","volume":"129","author":"Lu","year":"2019","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.dmpk.2025.101478_bib155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.toxrep.2017.02.001","article-title":"Evaluation of a human in vitro hepatocyte-NPC co-culture model for the prediction of idiosyncratic drug-induced liver injury: a pilot study","volume":"4","author":"Granitzny","year":"2017","journal-title":"Toxicol Rep"},{"issue":"7","key":"10.1016\/j.dmpk.2025.101478_bib156","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.tiv.2009.07.026","article-title":"Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model","volume":"23","author":"Edling","year":"2009","journal-title":"Toxicol Vitro"},{"key":"10.1016\/j.dmpk.2025.101478_bib157","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00204-016-1686-y","article-title":"Characterization of chemical-induced sterile inflammation in vitro: application of the model compound ketoconazole in a human hepatic co-culture system","volume":"91","author":"Wewering","year":"2017","journal-title":"Arch Toxicol"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib158","first-page":"4","article-title":"Recreating gut-liver axis during NAFLD onset by using a Caco-2\/HepG2 co-culture system. Metabolism and Target Organ Damage","volume":"2","author":"Marica","year":"2022"},{"key":"10.1016\/j.dmpk.2025.101478_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10544-019-0414-9","article-title":"A liver-chip-based alcoholic liver disease model featuring multi-non-parenchymal cells","volume":"21","author":"Deng","year":"2019","journal-title":"Biomed Microdevices"},{"issue":"23","key":"10.1016\/j.dmpk.2025.101478_bib160","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1039\/C5LC00874C","article-title":"Liver injury-on-a-chip: microfluidic co-cultures with integrated biosensors for monitoring liver cell signaling during injury","volume":"15","author":"Zhou","year":"2015","journal-title":"Lab Chip"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib161","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1039\/C5IB00298B","article-title":"A 3D alcoholic liver disease model on a chip","volume":"8","author":"Lee","year":"2016","journal-title":"Integr Biol"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109393","article-title":"Modeling alcohol-associated liver disease in a human Liver-Chip","volume":"36","author":"Nawroth","year":"2021","journal-title":"Cell Rep"},{"issue":"18","key":"10.1016\/j.dmpk.2025.101478_bib163","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1039\/C9LC00354A","article-title":"A microfluidic patterned model of non-alcoholic fatty liver disease: applications to disease progression and zonation","volume":"19","author":"Bulutoglu","year":"2019","journal-title":"Lab Chip"},{"key":"10.1016\/j.dmpk.2025.101478_bib164","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.actbio.2021.07.013","article-title":"Modeling nonalcoholic fatty liver disease on a liver lobule chip with dual blood supply","volume":"134","author":"Du","year":"2021","journal-title":"Acta Biomater"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep4.1647","article-title":"Human nonalcoholic steatohepatitis on a chip","volume":"5","author":"Freag","year":"2021","journal-title":"Hepatol Commun"},{"issue":"7","key":"10.1016\/j.dmpk.2025.101478_bib166","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159729","article-title":"Investigating nonalcoholic fatty liver disease in a liver-on-a-chip microfluidic device","volume":"11","author":"Gori","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib167","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92264-2","article-title":"Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation","volume":"11","author":"Slaughter","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.dmpk.2025.101478_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120904","article-title":"A scalable and sensitive steatosis chip with long-term perfusion of in situ differentiated HepaRG organoids","volume":"275","author":"Teng","year":"2021","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.dmpk.2025.101478_bib169","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1021\/acsbiomaterials.0c00682","article-title":"Modeling human nonalcoholic fatty liver disease (NAFLD) with an organoids-on-a-chip system","volume":"6","author":"Wang","year":"2020","journal-title":"ACS Biomater Sci Eng"},{"issue":"22","key":"10.1016\/j.dmpk.2025.101478_bib170","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1177\/15353702211009228","article-title":"Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors","volume":"246","author":"Saydmohammed","year":"2021","journal-title":"Exp Biol Med"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib171","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s42003-021-02616-x","article-title":"Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system","volume":"4","author":"Kostrzewski","year":"2021","journal-title":"Commun Biol"},{"issue":"24","key":"10.1016\/j.dmpk.2025.101478_bib172","article-title":"In vitro human liver model of nonalcoholic steatohepatitis by coculturing hepatocytes, endothelial cells, and Kupffer cells","volume":"8","author":"Suurmond","year":"2019","journal-title":"Adv Healthcare Mater"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101478_bib173","article-title":"A human liver\u2010on\u2010a\u2010chip platform for modeling nonalcoholic fatty liver disease","volume":"3","author":"Lasli","year":"2019","journal-title":"Adv Biosyst"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib174","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41467-018-02969-8","article-title":"3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection","volume":"9","author":"Ortega-Prieto","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/mi8010027","article-title":"Human liver sinusoid on a chip for hepatitis B virus replication study","volume":"8","author":"Kang","year":"2017","journal-title":"Micromachines"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib176","doi-asserted-by":"crossref","DOI":"10.1063\/1.5070088","article-title":"A cell lines derived microfluidic liver model for investigation of hepatotoxicity induced by drug-drug interaction","volume":"13","author":"Deng","year":"2019","journal-title":"Biomicrofluidics"},{"issue":"23","key":"10.1016\/j.dmpk.2025.101478_bib177","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1039\/C8LC00869H","article-title":"In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system","volume":"18","author":"Wang","year":"2018","journal-title":"Lab Chip"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib178","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.cclet.2021.11.029","article-title":"A 3D bio-printed spheroids based perfusion in vitro liver on chip for drug toxicity assays","volume":"33","author":"Tian","year":"2022","journal-title":"Chin Chem Lett"},{"issue":"16","key":"10.1016\/j.dmpk.2025.101478_bib179","doi-asserted-by":"crossref","first-page":"E2231","DOI":"10.1073\/pnas.1522556113","article-title":"Real-time monitoring of metabolic function in liver-on-chip microdevices tracks the dynamics of mitochondrial dysfunction","volume":"113","author":"Bavli","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"10.1016\/j.dmpk.2025.101478_bib180","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1039\/C8LC01029C","article-title":"A lung\/liver-on-a-chip platform for acute and chronic toxicity studies","volume":"18","author":"Bovard","year":"2018","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib181","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1038\/s41598-020-64219-6","article-title":"Human multi-organ chip co-culture of bronchial lung culture and liver spheroids for substance exposure studies","volume":"10","author":"Schimek","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib182","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ab6d36","article-title":"Drug compound screening in single and integrated multi-organoid body-on-a-chip systems","volume":"12","author":"Skardal","year":"2020","journal-title":"Biofabrication"},{"issue":"517","key":"10.1016\/j.dmpk.2025.101478_bib183","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax5516","article-title":"Reproducing human and cross-species drug toxicities using a Liver-Chip","volume":"11","author":"Jang","year":"2019","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib184","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1021\/acsbiomaterials.9b01735","article-title":"Application of gelatin bioinks and cell-printing technology to enhance cell delivery capability for 3D liver fibrosis-on-a-chip development","volume":"6","author":"Lee","year":"2020","journal-title":"ACS Biomater Sci Eng"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101478_bib185","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1021\/acsbiomaterials.1c00642","article-title":"Usability of polydimethylsiloxane-based microfluidic devices in pharmaceutical research using human hepatocytes","volume":"7","author":"Deguchi","year":"2021","journal-title":"ACS Biomater Sci Eng"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib186","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/ijms17020224","article-title":"Hepatotoxicity by drugs: the most common implicated agents","volume":"17","author":"Bj\u00f6rnsson","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib187","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.28323","article-title":"Categorization of drugs implicated in causing liver injury: critical assessment based on published case reports","volume":"63","author":"Bj\u00f6rnsson","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib188","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/j.gastro.2014.12.007","article-title":"Discrepancies in liver disease labeling in the package inserts of commonly prescribed medications","volume":"148","author":"Bjornsson","year":"2015","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib189","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s00204-016-1845-1","article-title":"Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man","volume":"90","author":"Dragovic","year":"2016","journal-title":"Arch Toxicol"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1039\/C9LC00768G","article-title":"Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry","volume":"20","author":"Baudy","year":"2020","journal-title":"Lab Chip"},{"issue":"7","key":"10.1016\/j.dmpk.2025.101478_bib191","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00044-020-02567-8","article-title":"Drug\u2013protein adducts: past, present, and future","volume":"29","author":"Baillie","year":"2020","journal-title":"Med Chem Res"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib192","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.3390\/ijms23063315","article-title":"Mitochondria as the target of hepatotoxicity and drug-induced liver injury: molecular mechanisms and detection methods","volume":"23","author":"Mihajlovic","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib193","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0163-7258(95)00012-6","article-title":"Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity","volume":"67","author":"Fromenty","year":"1995","journal-title":"Pharmacol Therapeut"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib194","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1472-8206.2008.00608.x","article-title":"Drug\u2010induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies","volume":"22","author":"Labbe","year":"2008","journal-title":"Fund Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2025.101478_bib195","series-title":"Adverse drug reactions","first-page":"311","article-title":"Mitochondrial involvement in drug-induced liver injury","author":"Pessayre","year":"2010"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib196","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib197","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/hsz-2019-0270","article-title":"Emerging mechanisms of drug-induced phospholipidosis","volume":"401","author":"Breiden","year":"2020","journal-title":"Biol Chem"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib198","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.tcb.2014.06.006","article-title":"Lysosome: regulator of lipid degradation pathways","volume":"24","author":"Settembre","year":"2014","journal-title":"Trends Cell Biol"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib199","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/hep.21359","article-title":"Hepatobiliary transporters and drug-induced cholestasis","volume":"44","author":"Pauli-Magnus","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib200","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/03602532.2011.605790","article-title":"Genetic association studies in drug-induced liver injury","volume":"44","author":"Daly","year":"2012","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.dmpk.2025.101478_bib201","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cotox.2017.12.006","article-title":"Immune drug-induced liver disease and drugs","volume":"10","author":"Waddington","year":"2018","journal-title":"Curr Opin Toxicol"},{"issue":"11","key":"10.1016\/j.dmpk.2025.101478_bib202","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3390\/cells12111476","article-title":"Microphysiological models for mechanistic-based prediction of idiosyncratic DILI","volume":"12","author":"Stern","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib203","first-page":"331","article-title":"Immune mechanisms in acetaminophen-induced acute liver failure","volume":"3","author":"Krenkel","year":"2014","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib204","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/00498250310001657568","article-title":"Phase I and II enzyme characterization of two sources of HepG2 cell lines","volume":"34","author":"Hewitt","year":"2004","journal-title":"Xenobiotica"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101478_bib205","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1021\/tx300091x","article-title":"In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs","volume":"25","author":"Thompson","year":"2012","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib206","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/toxsci\/kfs083","article-title":"Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs","volume":"127","author":"Tolosa","year":"2012","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib207","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1353\/pbm.1968.0004","article-title":"The spectrum of hepatotoxicity","volume":"12","author":"Zimmerman","year":"1968","journal-title":"Perspect Biol Med"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib208","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug\u2010induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Therapeut"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib209","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1586\/egh.10.8","article-title":"Biomarkers for drug-induced liver injury","volume":"4","author":"Shi","year":"2010","journal-title":"Expet Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib210","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/faat.1996.0022","article-title":"Harmonization of animal clinical pathology testing in toxicity and safety studies","volume":"29","author":"Weingand","year":"1996","journal-title":"Fund Appl Toxicol"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib211","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/clinchem\/46.12.2027","article-title":"Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests","volume":"46","author":"Dufour","year":"2000","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib212","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1939-165X.2005.tb00041.x","article-title":"Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies","volume":"34","author":"Boone","year":"2005","journal-title":"Vet Clin Pathol"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib213","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1016\/j.apsb.2021.11.013","article-title":"Preclinical models of idiosyncratic drug-induced liver injury (iDILI): moving towards prediction","volume":"11","author":"Segovia-Zafra","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib214","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.26294","article-title":"Mechanistic biomarkers provide early and sensitive detection of acetaminophen\u2010induced acute liver injury at first presentation to hospital","volume":"58","author":"Antoine","year":"2013","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101478_bib215","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1111\/bcp.15724","article-title":"Evaluation of diagnostic and prognostic candidate biomarkers in drug\u2010induced liver injury vs. other forms of acute liver damage","volume":"89","author":"Cueto\u2010S\u00e1nchez","year":"2023","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib286","doi-asserted-by":"crossref","DOI":"10.1038\/srep35434","article-title":"Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability","volume":"6","author":"Hendriks","year":"2016","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101478_bib287","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00204-017-2002-1","article-title":"Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury","volume":"91","author":"Proctor","year":"2017","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.dmpk.2025.101478_bib288","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.153829","article-title":"A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction","volume":"505","author":"Sun","year":"2024","journal-title":"Toxicology"},{"key":"10.1016\/j.dmpk.2025.101478_bib289","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115279","article-title":"HepG2 (C3A) spheroids show higher sensitivity compared to HepaRG spheroids for drug-induced liver injury (DILI)","volume":"408","author":"Basharat","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101478_bib290","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/2472555217701058","article-title":"An automated multiplexed hepatotoxicity and CYP induction assay using HepaRG cells in 2D and 3D","volume":"22","author":"Ott","year":"2017","journal-title":"SLAS Discovery"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib218","first-page":"229","article-title":"A novel MicroRNA signature for cholestatic drugs in human hepatocytes and its translation into novel circulating biomarkers for drug-induced liver injury patients","volume":"173","author":"L\u00f3pez-Riera","year":"2019","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/aivt.2020.0008","article-title":"Exosomal microRNAs release as a sensitive marker for drug-induced liver injury in vitro","volume":"6","author":"Messner","year":"2020","journal-title":"Appl In Vitro Toxicol"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib221","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00204-017-2090-y","article-title":"Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans","volume":"92","author":"Yu","year":"2018","journal-title":"Arch Toxicol"},{"issue":"11","key":"10.1016\/j.dmpk.2025.101478_bib225","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1155\/2014\/757929","article-title":"Biomarkers in nonalcoholic fatty liver disease","volume":"28","author":"Neuman","year":"2014","journal-title":"Canadian J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib227","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yexcr.2004.02.019","article-title":"Keratin 8\/18 breakdown and reorganization during apoptosis","volume":"297","author":"Schutte","year":"2004","journal-title":"Exp Cell Res"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101478_bib228","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/0008-5472.CAN-03-2455","article-title":"Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18","volume":"64","author":"Kramer","year":"2004","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib231","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1038\/s41598-020-61270-1","article-title":"New insights in acetaminophen toxicity: HMGB1 contributes by itself to amplify hepatocyte necrosis in vitro through the TLR4-TRIF-RIPK3 axis","volume":"10","author":"Minsart","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib239","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40360-017-0168-z","article-title":"Short-term treatment with taurolidine is associated with liver injury","volume":"18","author":"Fahrner","year":"2017","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10565-016-9316-2","article-title":"The HepaRG cell line, a superior in vitro model to L-02, HepG2 and hiHeps cell lines for assessing drug-induced liver injury","volume":"32","author":"Wu","year":"2016","journal-title":"Cell Biol Toxicol"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib291","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.29802","article-title":"Candidate biomarkers for the diagnosis and prognosis of drug\u2010induced liver injury: an international collaborative effort","volume":"69","author":"Church","year":"2019","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101478_bib292","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/liv.12197","article-title":"High levels of circulating HMGB1 as a biomarker of acute liver failure in patients with viral hepatitis E","volume":"33","author":"Majumdar","year":"2013","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib293","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/biom12040544","article-title":"Progress in assays of HMGB1 levels in human plasma\u2014the potential prognostic value in COVID-19","volume":"12","author":"\u0160tros","year":"2022","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.dmpk.2025.101478_bib216","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.tibs.2012.08.003","article-title":"Extracellular miRNAs: the mystery of their origin and function","volume":"37","author":"Turchinovich","year":"2012","journal-title":"Trends Biochem Sci"},{"issue":"41","key":"10.1016\/j.dmpk.2025.101478_bib217","doi-asserted-by":"crossref","first-page":"14888","DOI":"10.1073\/pnas.1408301111","article-title":"Quantitative and stoichiometric analysis of the microRNA content of exosomes","volume":"111","author":"Chevillet","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib219","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/14737159.2018.1415145","article-title":"MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury","volume":"18","author":"Howell","year":"2018","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.dmpk.2025.101478_bib222","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1007\/s00204-021-03121-0","article-title":"The application of cytokeratin-18 as a biomarker for drug-induced liver injury","volume":"95","author":"Korver","year":"2021","journal-title":"Arch Toxicol"},{"issue":"11","key":"10.1016\/j.dmpk.2025.101478_bib223","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/liv.13441","article-title":"The transformation in biomarker detection and management of drug\u2010induced liver injury","volume":"37","author":"Church","year":"2017","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib224","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1083\/jcb.138.6.1379","article-title":"Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis","volume":"138","author":"Caul\u00edn","year":"1997","journal-title":"J Cell Biol"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101478_bib226","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2013.12.026","article-title":"Biomarkers of liver cell death","volume":"60","author":"Eguchi","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.dmpk.2025.101478_bib229","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.phrs.2016.06.031","article-title":"HMGB1 as biomarker and drug target","volume":"111","author":"Venereau","year":"2016","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101478_bib230","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/JLB.3MR0121-277R","article-title":"HMGB1: an overview of its roles in the pathogenesis of liver disease","volume":"110","author":"Ni","year":"2021","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib232","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1139\/O09-008","article-title":"Human GLUD1 and GLUD2 glutamate dehydrogenase localize to mitochondria and endoplasmic reticulum","volume":"87","author":"Mastorodemos","year":"2009","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.dmpk.2025.101478_bib233","series-title":"Comprehensive medicinal chemistry III","first-page":"255","article-title":"4.15 - emerging translatable safety biomarkers","author":"Tarrant","year":"2017"},{"key":"10.1016\/j.dmpk.2025.101478_bib234","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/bs.apha.2019.02.001","article-title":"Biomarkers of drug-induced liver injury","volume":"85","author":"McGill","year":"2019","journal-title":"Adv Pharmacol"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101478_bib235","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/14737159.2018.1508998","article-title":"Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation","volume":"18","author":"McGill","year":"2018","journal-title":"Expert Rev Mol Diagn"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101478_bib236","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1172\/JCI59755","article-title":"The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation","volume":"122","author":"McGill","year":"2012","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib237","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/01926230252929945","article-title":"Alpha-glutathione S-transferase in the assessment of hepatotoxicity\u2014its diagnostic utility in comparison with other recognized markers in the Wistar Han rat","volume":"30","author":"Giffen","year":"2002","journal-title":"Toxicol Pathol"},{"issue":"10","key":"10.1016\/j.dmpk.2025.101478_bib238","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1111\/bcp.15807","article-title":"Glutamate dehydrogenase combined with ferrochelatase as a biomarker of liver injury induced by antituberculosis drugs","volume":"89","author":"He","year":"2023","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib241","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul Toxicol Pharmacol"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib242","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.stemcr.2023.10.020","article-title":"Deriving early single-rosette brain organoids from human pluripotent stem cells","volume":"18","author":"Tidball","year":"2023","journal-title":"Stem Cell Rep"},{"issue":"34","key":"10.1016\/j.dmpk.2025.101478_bib243","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj2800","article-title":"Spectroscopic label-free microscopy of changes in live cell chromatin and biochemical composition in transplantable organoids","volume":"7","author":"Pettinato","year":"2021","journal-title":"Sci Adv"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib244","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/bioengineering9030121","article-title":"Present application and perspectives of organoid imaging technology","volume":"9","author":"Fei","year":"2022","journal-title":"Bioengineering"},{"issue":"22","key":"10.1016\/j.dmpk.2025.101478_bib245","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022113213","article-title":"Morphogenesis and development of human telencephalic organoids in the absence and presence of exogenous extracellular matrix","volume":"42","author":"Martins\u2010Costa","year":"2023","journal-title":"EMBO J"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101478_bib246","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/pmic.200900758","article-title":"Matrigel: a complex protein mixture required for optimal growth of cell culture","volume":"10","author":"Hughes","year":"2010","journal-title":"Proteomics"},{"issue":"1750","key":"10.1016\/j.dmpk.2025.101478_bib247","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2017.0230","article-title":"Developing defined substrates for stem cell culture and differentiation","volume":"373","author":"Hagbard","year":"2018","journal-title":"Phil Trans Biol Sci"},{"key":"10.1016\/j.dmpk.2025.101478_bib248","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biomaterials.2015.10.011","article-title":"Proteomic analysis of naturally-sourced biological scaffolds","volume":"75","author":"Li","year":"2016","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.dmpk.2025.101478_bib249","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nbt1001-971","article-title":"Feeder-free growth of undifferentiated human embryonic stem cells","volume":"19","author":"Xu","year":"2001","journal-title":"Nat Biotechnol"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101478_bib250","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/ar.23567","article-title":"Basement membrane type IV collagen and laminin: an overview of their biology and value as fibrosis biomarkers of liver disease","volume":"300","author":"Mak","year":"2017","journal-title":"Anat Rec"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib251","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/j.gastro.2013.11.034","article-title":"Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion","volume":"146","author":"Williams","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dmpk.2025.101478_bib252","series-title":"Seminars in liver disease. 21. Copyright\u00a9 2001","first-page":"373","article-title":"Extracellular matrix degradation and the role of hepatic stellate cells","author":"Benyon","year":"2001"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101478_bib253","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/gutjnl-2014-308410","article-title":"Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis","volume":"64","author":"Dubuquoy","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib254","doi-asserted-by":"crossref","DOI":"10.1038\/srep27398","article-title":"The alterations in the extracellular matrix composition guide the repair of damaged liver tissue","volume":"6","author":"Klaas","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101478_bib255","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/gut.2009.182345","article-title":"Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver","volume":"59","author":"Lorenzini","year":"2010","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.dmpk.2025.101478_bib256","first-page":"757","article-title":"Liver progenitor cell interactions with the extracellular matrix","volume":"7","author":"Zhu","year":"2013","journal-title":"J Tissue Eng Regen Med"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101478_bib257","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/bioengineering9030110","article-title":"Design by nature: emerging applications of native liver extracellular matrix for cholangiocyte organoid-based regenerative medicine","volume":"9","author":"Willemse","year":"2022","journal-title":"Bioengineering"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101478_bib258","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","article-title":"Drug\u2010induced liver injury in a Swedish University hospital out\u2010patient hepatology clinic","volume":"24","author":"De Valle","year":"2006","journal-title":"Aliment Pharmacol Therapeut"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101478_bib259","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.2004.02133.x","article-title":"Acute and clinically relevant drug\u2010induced liver injury: a population based case\u2010control study","volume":"58","author":"De Abajo","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib260","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.dmpk.2025.101478_bib261","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bj\u00f6rnsson","year":"2013","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101478_bib262","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","article-title":"Incidence and etiology of drug-induced liver injury in mainland China","volume":"156","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101478_bib263","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/pds.3388","article-title":"Characterizing phenotypes and outcomes of drug\u2010associated liver injury using electronic medical record data","volume":"22","author":"Shin","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib264","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","article-title":"Human iPSC-based modeling of late-onset disease via progerin-induced aging","volume":"13","author":"Miller","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib265","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.stem.2015.05.004","article-title":"Programming and reprogramming cellular age in the era of induced pluripotency","volume":"16","author":"Studer","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"52","key":"10.1016\/j.dmpk.2025.101478_bib266","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-genet-120417-031534","article-title":"Aging in a dish: iPSC-derived and directly induced neurons for studying brain aging and age-related neurodegenerative diseases","volume":"52","author":"Mertens","year":"2018","journal-title":"Annu Rev Genet"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101478_bib267","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/hep4.1064","article-title":"Idiosyncratic drug\u2010induced liver injury: a short review","volume":"1","author":"Yamashita","year":"2017","journal-title":"Hepatol Commun"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436725004288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436725004288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:32:30Z","timestamp":1777609950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436725004288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":293,"alternative-id":["S1347436725004288"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2025.101478","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro liver models for toxicological research","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2025.101478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101478"}}